0001171843-23-001595.txt : 20230310
0001171843-23-001595.hdr.sgml : 20230310
20230310165115
ACCESSION NUMBER: 0001171843-23-001595
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230309
FILED AS OF DATE: 20230310
DATE AS OF CHANGE: 20230310
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Blanchard Cheryl R
CENTRAL INDEX KEY: 0001326530
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-14027
FILM NUMBER: 23724421
MAIL ADDRESS:
STREET 1: C/O ZIMMER, INC.
STREET 2: P.O. BOX 708
CITY: WARSAW
STATE: IN
ZIP: 46580
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Anika Therapeutics, Inc.
CENTRAL INDEX KEY: 0000898437
STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
IRS NUMBER: 043145961
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 32 WIGGINS AVENUE
CITY: BEDFORD
STATE: MA
ZIP: 01730
BUSINESS PHONE: (781) 457-9000
MAIL ADDRESS:
STREET 1: 32 WIGGINS AVENUE
CITY: BEDFORD
STATE: MA
ZIP: 01730
FORMER COMPANY:
FORMER CONFORMED NAME: ANIKA THERAPEUTICS INC
DATE OF NAME CHANGE: 19970114
FORMER COMPANY:
FORMER CONFORMED NAME: ANIKA RESEARCH INC
DATE OF NAME CHANGE: 19930309
4
1
ownership.xml
X0306
4
2023-03-09
0
0000898437
Anika Therapeutics, Inc.
ANIK
0001326530
Blanchard Cheryl R
32 WIGGINS AVENUE
BEDFORD
MA
01730
1
1
0
0
President, CEO, Director
Common Stock
2023-03-09
4
M
0
14419
0
A
87963
D
Common Stock
2023-03-09
4
F
0
4232
26.91
D
83731
D
Common Stock
11742
I
Revocable Trust
Restricted Stock Unit
0.00
2023-03-09
4
A
0
60004
0
A
Common Stock
60004
60004
D
Stock Option (Right to Buy)
29.60
2023-03-09
4
A
0
130998
0
A
2033-03-09
Common Stock
130998
130998
D
Restricted Stock Unit
0.00
2023-03-09
4
M
0
14419
0
D
Common Stock
14419
14420
D
Reflects the second vesting installment of Restricted Stock Units (RSUs) granted on March 9, 2021.
Includes the following shares acquired under the Anika Therapeutics, Inc. Employee Stock Purchase Plan: 540 shares purchased on May 13, 2022 and 178 shares purchased on November 14, 2022.
Reflects an aggregate of 4,232 shares of common stock retained by the Issuer to satisfy tax withholding obligations with respect to RSUs that vested on March 9, 2023.
Reflects the closing price of ANIK common stock on March 9, 2023, the trading day on which the vesting of RSUs gave rise to tax withholding obligations.
Consists of shares transferred by Dr. Blanchard to The Cheryl R. Blanchard Amended and Restated Revocable Trust dated December 19, 2014, of which Dr. Blanchard is a beneficiary and the sole trustee.
Each RSU represents the contingent right to receive one share of the Company's common stock. The RSUs vest in three equal annual installments beginning March 9, 2024.
Represents a 10% premium above the closing price of Anika's common stock on the date of grant.
The premium priced stock options vest in three equal annual installments beginning on March 9, 2024.
Each RSU represents the contingent right to receive one share of the Company's common stock. The RSUs vest in three equal annual installments beginning March 9, 2022.
/s/ Cheryl R. Blanchard
2023-03-10